GSK plc (LON:GSK) Receives Average Rating of “Moderate Buy” from Brokerages

GSK plc (LON:GSK) has been assigned a consensus recommendation of “Moderate Buy” from the seven analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is GBX 1,791.25 ($22.66).

GSK has been the topic of a number of research analyst reports. Shore Capital reaffirmed a “buy” rating on shares of GSK in a report on Thursday, June 27th. Barclays reissued an “equal weight” rating and issued a GBX 1,725 ($21.82) price target on shares of GSK in a research note on Tuesday, May 7th. Citigroup reissued a “buy” rating and issued a GBX 2,100 ($26.56) price target on shares of GSK in a research note on Monday, June 24th. JPMorgan Chase & Co. reissued an “underweight” rating on shares of GSK in a research note on Tuesday. Finally, Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,950 ($24.66) price target on shares of GSK in a research note on Friday, June 28th.

GSK Price Performance

LON:GSK opened at GBX 1,501 ($18.99) on Friday. The business’s 50-day moving average price is GBX 1,683.57 and its 200 day moving average price is GBX 1,632.74. The firm has a market cap of £61.24 billion, a P/E ratio of 1,379.36, a PEG ratio of 1.19 and a beta of 0.27. GSK has a 52-week low of GBX 1,302.60 ($16.48) and a 52-week high of GBX 1,823.50 ($23.06). The company has a quick ratio of 0.73, a current ratio of 0.87 and a debt-to-equity ratio of 134.34.

GSK Cuts Dividend

The firm also recently announced a dividend, which will be paid on Thursday, July 11th. Shareholders of record on Thursday, May 16th will be paid a dividend of GBX 15 ($0.19) per share. The ex-dividend date of this dividend is Thursday, May 16th. This represents a yield of 0.9%. GSK’s dividend payout ratio (DPR) is presently 5,504.59%.

Insider Buying and Selling at GSK

In other GSK news, insider Wendy Becker bought 446 shares of the stock in a transaction on Thursday, June 20th. The shares were bought at an average price of GBX 1,614 ($20.41) per share, with a total value of £7,198.44 ($9,105.03). Company insiders own 1.60% of the company’s stock.

GSK Company Profile

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.